Total Payments
$404,639
2024 Payments
$15,543
Companies
55
Transactions
2,121
Medicare Patients
6,378
Medicare Billing
$6.4M
Payment Breakdown by Category
Other$246,662 (61.0%)
Consulting$81,102 (20.0%)
Food & Beverage$43,851 (10.8%)
Travel$32,584 (8.1%)
Education$440.26 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $230,257 | 136 | 56.9% |
| Consulting Fee | $81,102 | 32 | 20.0% |
| Food and Beverage | $43,851 | 1,778 | 10.8% |
| Travel and Lodging | $32,584 | 142 | 8.1% |
| Honoraria | $16,406 | 13 | 4.1% |
| Education | $440.26 | 20 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $99,642 | 265 | $0 (2024) |
| ABBVIE INC. | $87,094 | 466 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $29,912 | 63 | $0 (2019) |
| UCB, Inc. | $29,086 | 206 | $0 (2024) |
| GENZYME CORPORATION | $26,356 | 33 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $26,012 | 81 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $21,713 | 44 | $0 (2024) |
| Janssen Biotech, Inc. | $19,571 | 153 | $0 (2024) |
| Horizon Pharma plc | $14,991 | 51 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,934 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,543 | 226 | ABBVIE INC. ($6,398) |
| 2023 | $15,960 | 218 | AbbVie Inc. ($10,746) |
| 2022 | $27,088 | 244 | ABBVIE INC. ($17,801) |
| 2021 | $24,333 | 198 | Mallinckrodt Hospital Products Inc. ($7,490) |
| 2020 | $51,733 | 210 | AbbVie Inc. ($15,724) |
| 2019 | $80,624 | 339 | Novartis Pharmaceuticals Corporation ($22,445) |
| 2018 | $109,146 | 369 | Novartis Pharmaceuticals Corporation ($35,865) |
| 2017 | $80,212 | 317 | Novartis Pharmaceuticals Corporation ($29,000) |
All Payment Transactions
2,121 individual payment records from CMS Open Payments — Page 1 of 85
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Immunology | ||||||
| 12/15/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $114.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Bone Health | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,270 | 74,005 | $3.8M | $1.2M |
| 2022 | 25 | 1,453 | 74,551 | $4.0M | $1.4M |
| 2021 | 28 | 1,766 | 105,731 | $4.5M | $1.8M |
| 2020 | 26 | 1,889 | 77,490 | $4.6M | $1.9M |
Total Patients
6,378
Total Services
331,777
Medicare Billing
$6.4M
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 38 | 40,250 | $1.6M | $421,949 | 26.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 7,725 | $540,750 | $259,908 | 48.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 131 | 13,440 | $369,600 | $245,381 | 66.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 18 | 4,890 | $586,800 | $128,064 | 21.8% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 33 | 3,984 | $147,408 | $52,641 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 567 | $139,275 | $50,509 | 36.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 34 | 220 | $132,000 | $23,287 | 17.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 49 | 322 | $96,600 | $16,637 | 17.2% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 47 | 177 | $44,250 | $10,962 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 159 | $28,170 | $10,192 | 36.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 26 | 204 | $40,800 | $4,652 | 11.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 42 | 104 | $15,600 | $4,279 | 27.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 147 | 378 | $15,120 | $4,185 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 80 | 366 | $5,124 | $3,074 | 60.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,550 | $2,675 | 31.3% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 18 | 36 | $3,960 | $894.72 | 22.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 14 | 65 | $2,275 | $811.85 | 35.7% |
| 73565 | X-ray of both knees while standing | Office | 2023 | 14 | 14 | $1,484 | $423.54 | 28.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 68 | 503 | $2,515 | $394.29 | 15.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 81 | 542 | $10,840 | $275.76 | 2.5% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 13 | 34 | $510.00 | $106.28 | 20.8% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 37 | 38,000 | $1.5M | $442,123 | 29.1% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 13 | 9,275 | $649,250 | $321,239 | 49.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 141 | 14,700 | $404,250 | $249,319 | 61.7% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 20 | 5,570 | $668,400 | $157,090 | 23.5% |
About Dr. Mohammed Abubaker, MD
Dr. Mohammed Abubaker, MD is a Internal Medicine healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396733796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Abubaker, MD has received a total of $404,639 in payments from pharmaceutical and medical device companies, with $15,543 received in 2024. These payments were reported across 2,121 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($230,257).
As a Medicare-enrolled provider, Abubaker has provided services to 6,378 Medicare beneficiaries, totaling 331,777 services with total Medicare billing of $6.4M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Marietta, GA
- Active Since 10/10/2005
- Last Updated 01/14/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396733796
Products in Payments
- COSENTYX (Biological) $76,690
- ACTHAR (Biological) $51,625
- RINVOQ (Biological) $31,390
- ORENCIA (Biological) $25,512
- Cimzia (Drug) $23,001
- KEVZARA (Drug) $17,678
- KEVZARA (Biological) $12,728
- TREMFYA (Drug) $12,360
- RINVOQ (Drug) $12,211
- OFEV (Drug) $9,848
- KRYSTEXXA (Drug) $9,824
- SIMPONI ARIA (Biological) $9,215
- Rinvoq (Biological) $9,198
- TALTZ (Drug) $8,647
- Humira (Biological) $7,444
- SKYRIZI (Biological) $7,379
- Otezla (Drug) $5,549
- RAYOS (Drug) $4,936
- KRYSTEXXA (Biological) $4,132
- COSENTYX (Drug) $3,642
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marietta
Ahmed Al-Badri, Md, MD
Internal Medicine — Payments: $88,349
Internal Medicine $88,349
Dr. Amyn Hirani, M.d, M.D
Internal Medicine — Payments: $68,603
Internal Medicine $68,603
Dr. Shinoj Pattali Jayavalsan, M.d, M.D
Internal Medicine — Payments: $18,051
Internal Medicine $18,051
Mrs. Lisa Lefkovits, Md, MD
Internal Medicine — Payments: $14,823
Internal Medicine $14,823
Dr. David Cantrell, Md, MD
Internal Medicine — Payments: $14,474
Internal Medicine $14,474
Dr. Rickey Washington, Md, MD
Internal Medicine — Payments: $12,660
Internal Medicine $12,660